Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance

Author:

Clay-Gilmour Alyssa I.12,Hildebrandt Michelle A. T.3,Brown Elizabeth E.4,Hofmann Jonathan N.5ORCID,Spinelli John J.67ORCID,Giles Graham G.8910ORCID,Cozen Wendy11,Bhatti Parveen1213,Wu Xifeng3,Waller Rosalie G.14,Belachew Alem A.3,Robinson Dennis P.15,Norman Aaron D.115,Sinnwell Jason P.15ORCID,Berndt Sonja I.5,Rajkumar S. Vincent16ORCID,Kumar Shaji K.16ORCID,Chanock Stephen J.5,Machiela Mitchell J.5,Milne Roger L.8910ORCID,Slager Susan L.15,Camp Nicola J.14,Ziv Elad17,Vachon Celine M.1ORCID

Affiliation:

1. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN;

2. Department of Biostatistics and Epidemiology, Arnold School of Public Health, University of South Carolina, Greenville, SC;

3. Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX;

4. Department of Pathology, School of Medicine at the; University of Alabama, Birmingham, AL;

5. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, MD;

6. Division of Population Oncology, BC Cancer, BC, Canada;

7. School of Population and Public Health, University of British Columbia, BC, Canada;

8. Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia;

9. Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia;

10. Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia;

11. Department of Preventive Medicine, Keck School of Medicine at University of Southern California, Los Angeles, CA;

12. Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

13. Cancer Control Research, BC Cancer, Vancouver, BC, Canada;

14. Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;

15. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and

16. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN; and

17. Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Abstract

Abstract So far, 23 germline susceptibility loci have been associated with multiple myeloma (MM) risk. It is unclear whether the genetic variation associated with MM susceptibility also predisposes to its precursor, monoclonal gammopathy of undetermined significance (MGUS). Leveraging 2434 MM cases, 754 MGUS cases, and 2 independent sets of controls (2567/879), we investigated potential shared genetic susceptibility of MM and MGUS by (1) performing MM and MGUS genome-wide association studies (GWAS); (2) validating the association of a polygenic risk score (PRS) based on 23 established MM loci (MM-PRS) with risk of MM, and for the first time with MGUS; and (3) examining genetic correlation of MM and MGUS. Heritability and genetic estimates yielded 17% (standard error [SE] ±0.04) and 15% (SE ±0.11) for MM and MGUS risk, respectively, and a 55% (SE ±0.30) genetic correlation. The MM-PRS was associated with risk of MM when assessed continuously (odds ratio [OR], 1.17 per SD; 95% confidence interval [CI], 1.13-1.21) or categorically (OR, 1.70; 95% CI, 1.38-2.09 for highest; OR, 0.71; 95% CI, 0.55-0.90 for lowest compared with middle quintile). The MM-PRS was similarly associated with MGUS (OR, 1.19 per SD; 95% CI, 1.14-1.26 as a continuous measure, OR, 1.77, 95%CI: 1.29-2.43 for highest and OR, 0.70, 95%CI: 0.50-0.98 for lowest compared with middle quintile). MM and MGUS associations did not differ by age, sex, or MM immunoglobulin isotype. We validated a 23-SNP MM-PRS in an independent series of MM cases and provide evidence for its association with MGUS. Our results suggest shared common genetic susceptibility to MM and MGUS.

Publisher

American Society of Hematology

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3